Efficacy of intrathecal methotrexate in children with high-risk medulloblastoma over three years: a retrospective study from a single center

PURPOSE: Chemotherapy is commonly used for treatment in children over three years old with high-risk medulloblastoma(MB). However, little is currently known about the therapeutic benefits and side effects of intrathecal methotrexate(MTX), warranting further research. METHODS: In this retrospective s...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yu-Tong, Wang, Yu, Zhong, Xiao-dan, Chang, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462507/
https://www.ncbi.nlm.nih.gov/pubmed/37474745
http://dx.doi.org/10.1007/s11060-023-04388-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462507/
https://www.ncbi.nlm.nih.gov/pubmed/37474745
http://dx.doi.org/10.1007/s11060-023-04388-2

Ejemplares similares